|
1
|
Lou Y and Liu S: The TIPE (TNFAIP8) family
in inflammation, immunity, and cancer. Mol Immunol. 49:4–7. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dong Q, Fu L, Zhao Y, Xie C, Li Q and Wang
E: TNFAIP8 interacts with LATS1 and promotes aggressiveness through
regulation of Hippo pathway in hepatocellular carcinoma.
Oncotarget. 8:15689–15703. 2017.PubMed/NCBI
|
|
3
|
Hadisaputri YE, Miyazaki T, Suzuki S,
Yokobori T, Kobayashi T, Tanaka N, Inose T, Sohda M and Kuwano H:
TNFAIP8 overexpression: Clinical relevance to esophageal squamous
cell carcinoma. Ann Surg Oncol. 19:S589–S596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu R, Qiu X, Hong S, Meng L, Hong X, Qiu
J, Yang J, Zhuang G and Liu Z: Clinical significance of TIPE
expression in gastric carcinoma. Onco Targets Ther. 9:4473–4481.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong QZ, Zhao Y, Liu Y, Wang Y, Zhang PX,
Jiang GY, Dong XJ, Cui QZ and Wang EH: Overexpression of SCC-S2
correlates with lymph node metastasis and poor prognosis in
patients with non-small-cell lung cancer. Cancer Sci.
101:1562–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao M, Xu Q, Lou C, Qin Y, Ning X, Liu T,
Zhao X, Jia S and Huang Y: Overexpression of TNFAIP8 is associated
with tumor aggressiveness and poor prognosis in patients with
invasive ductal breast carcinoma. Hum Pathol. 62:40–49. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu T, Gao H, Chen X, Lou G, Gu L, Yang M,
Xia B and Yin H: TNFAIP8 as a predictor of metastasis and a novel
prognostic biomarker in patients with epithelial ovarian cancer. Br
J Cancer. 109:1685–1692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pearson G, Robinson F, Gibson Beers T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang P, Han J and Hui L: MAPK signaling
in inflammation-associated cancer development. Protein Cell.
1:218–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Low HB and Zhang Y: Regulatory roles of
MAPK phosphatases in cancer. Immune Netw. 16:85–98. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leelahavanichkul K, Amornphimoltham P,
Molinolo AA, Basile JR, Koontongkaew S and Gutkind JS: A role for
p38 MAPK in head and neck cancer cell growth and tumor-induced
angiogenesis and lymphangiogenesis. Mol Oncol. 8:105–118. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Azijli K, Yuvaraj S, van Roosmalen I,
Flach K, Giovannetti E, Peters GJ, de Jong S and Kruyt FA: MAPK p38
and JNK have opposing activities on TRAIL-induced apoptosis
activation in NSCLC H460 cells that involves RIP1 and caspase-8 and
is mediated by Mcl-1. Apoptosis. 18:851–860. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dérijard B, Hibi M, Wu IH, Barrett T, Su
B, Deng T, Karin M and Davis RJ: JNK1: A protein kinase stimulated
by UV light and Ha-Ras that binds and phosphorylates the c-Jun
activation domain. Cell. 76:1025–1037. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ke SZ, Ni XY, Zhang YH, Wang YN, Wu B and
Gao FG: Camptothecin and cisplatin upregulate ABCG2 and MRP2
expression by activating the ATM/NF-κB pathway in lung cancer
cells. Int J Oncol. 42:1289–1296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YY, Liu Y, Ni XY, Bai ZH, Chen QY,
Zhang Y and Gao FG: Nicotine promotes cell proliferation and
induces resistance to cisplatin by α7 nicotinic acetylcholine
receptor-mediated activation in Raw264.7 and El4 cells. Oncol Rep.
31:1480–1488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jin HJ, Li HT, Sui HX, Xue MQ, Wang YN,
Wang JX and Gao FG: Nicotine stimulated bone marrow-derived
dendritic cells could augment HBV specific CTL priming by
activating PI3K-Akt pathway. Immunol Lett. 146:40–49. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hartley JW, Evans LH, Green KY, Naghashfar
Z, Macias AR, Zerfas PM and Ward JM: Expression of infectious
murine leukemia viruses by RAW264.7 cells, a potential complication
for studies with a widely used mouse macrophage cell line.
Retrovirology. 5:12008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kimura H, Lee C, Hayashi K, Yamauchi K,
Yamamoto N, Tsuchiya H, Tomita K, Bouvet M and Hoffman RM: UV light
killing efficacy of fluorescent protein-expressing cancer cells in
vitro and in vivo. J Cell Biochem. 110:1439–1446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang YN, Yan HQ, Huang XB, Wang YN, Li Q
and Gao FG: Interleukin 6 trigged ataxia-telangiectasia mutated
activation facilitates lung cancer metastasis via MMP-3/MMP-13
up-regulation. Oncotarget. 6:40719–40733. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Williams ES, Rodriguez-Bravo V,
Chippada-Venkata U, De Ia Iglesia-Vicente J, Gong Y, Galsky M, Oh
W, Cordon-Cardo C and Domingo-Domenech J: Generation of prostate
cancer patient derived xenograft models from circulating tumor
cells. J Vis Exp. 20:531822015.
|
|
22
|
Kumar D, Gokhale P, Broustas C,
Chakravarty D, Ahmad I and Kasid U: Expression of SCC-S2, an
antiapoptotic molecule, correlates with enhanced proliferation and
tumorigenicity of MDA-MB 435 cells. Oncogene. 23:612–616. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goldsmith JR and Chen YH: Regulation of
inflammation and tumorigenesis by the TIPE family of phospholipid
transfer proteins. Cell Mol Immunol. 14:482–487. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang SN, Lee KT, Tsai CJ, Chen YJ and Yeh
YT: Phosphorylated p38 and JNK MAPK proteins in hepatocellular
carcinoma. Eur J Clin Invest. 42:1295–1301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Samatar AA and Poulikakos PI: Targeting
RAS-ERK signalling in cancer: Promises and challenges. Nat Rev Drug
Discov. 13:928–942. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu F, Lv T, Chen G, Ye H, Wu W, Li G and
Zhi FC: Epigenetic silencing of DUSP9 induces the proliferation of
human gastric cancer by activating JNK signaling. Oncol Rep.
34:121–128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen YH, Godlewski J, Zhu J,
Sathyanarayana P, Leaner V, Birrer MJ, Rana A and Tzivion G:
Cross-talk between JNK/SAPK and ERK/MAPK pathways: Sustained
activation of JNK blocks ERK activation by mitogenic factors. J
Biol Chem. 278:26715–26721. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia Z, Dickens M, Raingeaud J, Davis RJ
and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases
on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu R, Liu W, Qiu X, Lin Z, Xie Y, Hong X,
Paerhati R, Qi Z, Zhuang G and Liu Z: Expression of tumor necrosis
factor-α-induced protein 8 in stage III gastric cancer and the
correlation with DcR3 and ERK1/2. Oncol Lett. 11:1835–1840. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perciavalle RM, Stewart DP, Koss B, Lynch
J, Milasta S, Bathina M, Temirov J, Cleland MM, Pelletier S,
Schuetz JD, et al: Anti-apoptotic MCL-1 localizes to the
mitochondrial matrix and couples mitochondrial fusion to
respiration. Nat Cell Biol. 14:575–583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu D, Li M, Tian Y, Liu J and Shang J:
Luteolin inhibits ROS-activated MAPK pathway in myocardial
ischemia/reperfusion injury. Life Sci. 122:15–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
